Bexsero, meningitis B vaccine

Bexsero, meningitis B vaccine

C026/3253 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 61.2MB

Downloadable file size: 9.4MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Bexsero, meningitis B vaccine. Pre-filled syringes of Bexsero, the meningococcal vaccine used against meningitis B, a disease caused by serogroup B of the Neisseria meningitidis bacterium. Meningitis is a potentially fatal inflammation of the brain membranes (meninges). This vaccine was developed by Novartis and approved for use in the European Union in January 2013. It was added to the UK childhood immunisation programme from 1 September 2015.

Release details: Model release not required. Property release not required.

Keywords: 2015, 21st century, bacterial, bexsero, childhood, glaxosmithkline, group b, immunisation, immunization, intramuscular, medical, medicine, meningitis b, meningococcal, neisseria meningitidis, no-one, nobody, novartis, packaging, packet, paediatric, paediatrics, pediatrics, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pre-filled, rdna, serogroup b, still life, still-life, studio shot, suspension, syringe, syringes, vaccine, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.